Cancer and Immune Signalling Lab (CISL)
jenkins-lab.bsky.social
Cancer and Immune Signalling Lab (CISL)
@jenkins-lab.bsky.social
Official site of the Jenkins Laboratory (CISL) at the South Australian immunoGENomics Cancer Institute (SAiGENCI), The University of Adelaide
Pinned
Wonderful to see so many people attend the Annual SAiGENCI Public Lecture last night to hear our research on the innate immune system, inflammation and immunotherapy in cancer. Fantastic talk also from my co-speaker Dr Mara Zeissig. Thank you to everyone.
www.youtube.com/watch?v=z2Kc...
SAiGENCI Annual Public Lecture 2025
YouTube video by Health & Medical Sciences - University of Adelaide
www.youtube.com
Very honoured to be the first Australian recipient of the prestigious Japanese Cancer Association (JCA) International Award, presented at the annual JCA2025 conference in Kanazawa. Special thanks to my JCA colleagues, especially JCA President, Prof Masanobu Oshima.
@saigenci.bsky.social
October 2, 2025 at 1:13 PM
We're hiring! Looking for talented Post-doctoral researchers in our program at SAiGENCI (Adelaide University) to study the role of the immune system in cancer. See below for details.....
careers.adelaide.edu.au/cw/en/job/51...
Learn more about South Australia's new university for the future.
careers.adelaide.edu.au
August 29, 2025 at 1:01 PM
Reposted by Cancer and Immune Signalling Lab (CISL)
Very grateful to the Ainsworth Foundation for their generous support and investment in our Tumour Inflammation and Immunotherapy Program at SAiGENCI.
www.adelaide.edu.au/newsroom/new...
Fellows advance immunotherapy and tumour inflammation research
www.adelaide.edu.au
July 28, 2025 at 7:49 AM
Very grateful to the Ainsworth Foundation for their generous support and investment in our Tumour Inflammation and Immunotherapy Program at SAiGENCI.
www.adelaide.edu.au/newsroom/new...
Fellows advance immunotherapy and tumour inflammation research
www.adelaide.edu.au
July 28, 2025 at 7:49 AM
Wonderful to see so many people attend the Annual SAiGENCI Public Lecture last night to hear our research on the innate immune system, inflammation and immunotherapy in cancer. Fantastic talk also from my co-speaker Dr Mara Zeissig. Thank you to everyone.
www.youtube.com/watch?v=z2Kc...
SAiGENCI Annual Public Lecture 2025
YouTube video by Health & Medical Sciences - University of Adelaide
www.youtube.com
May 7, 2025 at 10:58 AM
Reposted by Cancer and Immune Signalling Lab (CISL)
Academics get so jaded about institutions, when they reach a #leadership position many feel #researchculture is unactionable. Me and @deefitzgerald.bsky.social wrote a guide in @immunolcellbiol.bsky.social on leadership nurturing a positive culture 1/13

onlinelibrary.wiley.com/doi/10.1111/...
<em>Immunology & Cell Biology</em> | ASI Journal | Wiley Online Library
Positive research cultures provide the environment for scientists to explore ideas, grow as individuals, develop team science and create a positive impact on those around them. Here we focus on key a...
onlinelibrary.wiley.com
January 17, 2025 at 11:53 AM
x.com/Mohamed_I_Sa...
Proud to be a part of this NHMRC Ideas Grant ($1M) team to investigate the role of proteases in lung cancer.
@University of Adelaide
@SAiGENCI
x.com
x.com
December 22, 2024 at 11:41 AM
Reposted by Cancer and Immune Signalling Lab (CISL)
Big congratulations to Brendan Jenkins who has been selected as the recipient of the ICIS 2023 Distinguished Service Award! @Lab_Jenkins @ciiid_Hudson @Hudson_research @Monashuni @SAiGENCI @UniofAdelaide...
November 21, 2024 at 6:03 PM
Reposted by Cancer and Immune Signalling Lab (CISL)
Research Group Leaders in “Tumour Inflammation and Immunotherapy Program” at SAiGENCI...
November 21, 2024 at 6:15 PM
Reposted by Cancer and Immune Signalling Lab (CISL)
📢💻🧪 2 #PhD #Scholarships available @SAiGENCI:

1) Hybrid wet-dry: #multiomics to predict neoadjuvant response in #cancer

2) #Bioinformatics, comp-bio: large-scale #singlecell modelling and infrastructure

🔗https://researchers.adelaide.edu.au/profile/stefano.mangiola#my-research

Please share! 🙏
November 15, 2024 at 1:02 AM